|
|
|
9/16/2021
|
|
When:
|
Thursday, September 16 8:30 am
|
|
Where:
|
Virtual United States
|
|
Contact:
|
Delaware BioScience Association
info@delawarebio.org
(302) 635-0445
|
Online registration is closed.
|
|
« Go to Upcoming Event List
|
|
|

Member Showcase
Although live events aren’t possible right now, our connectivity and collaboration go on! Join us on Thursday, September 16th at 8:30 am to experience the same great BioBreakfast event in a virtual setting. The September BioBreakfast will provide an important update on the industry's response to the pandemic along with our always popular annual Member Showcase. Phyllis Arthur, Vice President, Infectious Diseases and Emerging Science Policy at BIO (Biotechnology Innovation Organization), will provide an important, timely briefing on where we stand fighting the pandemic. Phyllis will share the latest on the development of new vaccines and therapeutics, the regulatory and public health landscape for boosters and children under 12 and the industry’s efforts to expand vaccine access globally.
Then Delaware Bio member organizations will participate in the annual Member Showcase. The Member Showcase brings recognition to our outstanding Delaware Bio member organizations and institutions – particularly our newest members – providing an opportunity to highlight their products, services and research that foster the growth and prosperity of the Delaware bioscience community.
Event Speaker
|
| Phyllis Arthur |
| Vice President, Infectious Diseases and Emerging Science Policy
|
| Biotechnology Innovation Organization |
Phyllis Arthur is Vice President for Infectious Diseases and Emerging Science Policy at the Biotechnology Innovation Organization (BIO). In this role Ms. Arthur is responsible for working with member companies in vaccines, antimicrobial resistance, molecular diagnostics and biodefense on policy, legislative and regulatory issues.
Ms Arthur joined BIO in July 2009 as the Director of Healthcare Regulatory Affairs. Prior to joining BIO, she worked in numerous marketing and sales positions for Merck & Co Inc in their Vaccine Division. Over her 16-year career in vaccines, Ms Arthur launched several exciting new vaccines in the United States and internationally, including the first HPV vaccine, GARDASIL. During her years in Marketing, she worked closely with clinical and academic thought leaders in infectious diseases, oncology and public health. In addition, Ms Arthur also led a large vaccine sales organization of over 75 representatives and managers covering 14 states.
Before graduate school, Ms Arthur worked as a research assistant for two economists at the Brookings Institution in Washington, DC. There she conducted economic analyses related to savings and investment policies for the OECD countries.
Ms Arthur received her B.A. in 1987 in Economics and International Politics from Goucher College and her M.B.A. in 1991 from the Wharton School of Business at the University of Pennsylvania. |
Series Sponsors
|
|
|